Yourway plans new depot in Ireland to support clinical trials offering
The site provides access to a substantial domestic clinical trials market and several international locations.

The site provides access to a substantial domestic clinical trials market and several international locations.
The trial is designed to assess the use of Krystexxa with methotrexate to help patients achieve durable response to therapy.
The merged company will operate as ICON from 150 locations across 47 countries.
Horizon Therapeutics has enrolled the first patient in a clinical trial of Krystexxa (pegloticase injection) plus methotrexate for treating people…
Irish company ICON has agreed to acquire contract research company PRA Health Sciences in a cash and stock deal valued…
Researchers at RCSI University of Medicine and Health Sciences in Ireland have started a clinical trial to assess alpha-1-antitrypsin as…
Accenture will partner with Bayer to implement the Accenture INTIENT Clinical platform for research, clinical development, pharmacovigilance and patient services.
PCI Pharma is set to invest in a new clinical facility near Dublin, Ireland to significantly increase capabilities and capacity…
Thank you for subscribing to Clinical Trials Arena